The growing body of public DNA methylation datasets for a variety of cancer types provides data to enable discovery of novel clinical biomarkers for both early detection of tumours and monitoring of minimal residual disease. DNA methylation can be modified by environmental exposures and is associated with a wide range of diseases including developmental pathologies and cancer, where methylation changes are particularly pronounced.
The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.ĭNA cytosine methylation is a key epigenetic mark associated with gene regulation and function. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
0 kommentar(er)
